Announcing the launch of CTM-E Innovation Labs
Counter-Terrorism Medicine Europe (CTM-E) announces the launch of a new pilot program: the CTM-E Innovation Labs.
Serving as the dedicated research and development arm of Counter-Terrorism Medicine Europe, the Innovation Labs represent an important step forward in high-threat medical readiness. The innovation program plans to bridge the gap between clinical necessity and technological possibility, turning the complex challenges of disaster zones and high-threat environments into the next generation of medical solutions.
In modern crisis scenarios, medical personnel routinely operate under extreme constraints where standard clinical equipment and protocols can easily fall short. The CTM-E Innovation Labs will serve as a collaborative sandbox that brings together leading clinicians, academic researchers, and forward-thinking technology developers to rapidly prototype and validate tools designed for the realities of the field.
The Innovation Labs will provide the unique ecosystem needed for ideas to succeed:
Clinical feedback loops - Direct access to active tactical medics and disaster response teams who test your prototypes in simulated high-stress environments.
Regulatory guidance - Expert navigation of EU medical device regulations (MDR) specifically for emergency-use equipment.
Operational validation - Stress-testing technology against real-world scenarios, including CBRNe (Chemical, Biological, Radiological, Nuclear, and high-yield Explosive) threats.
The first steps of the Pilot Program will include solutions destined for:
Austere & high-threat medical equipment - Engineering lightweight, ruggedised, and highly adaptive medical tools that withstand the physical rigours of a tactical or disaster environment.
Prolonged field care solutions - Developing technologies designed to sustain critical patients when evacuation chains are delayed or compromised.
Clinical doctrine iteration - Translating real-world, real-time data from complex emergencies into agile clinical protocols.
By embedding technical innovation directly into the clinical realities of disaster and counter-terrorism medicine, the program aims to deliver solutions that are not just technologically advanced, but instantly operational where they matter most.
The first expression-of-interest forms for innovators, mentors and partners will be available on August 1st, 2026.
